AMGN
Amgen Inc
NASDAQ: AMGN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$346.25
+2.43% today
Updated 2026-04-30
Market cap
$182.22B
P/E ratio
23.75
P/S ratio
4.96x
EPS (TTM)
$14.23
Dividend yield
2.80%
52W range
$253 – $391
Volume
2.6M
Amgen Inc (AMGN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $33.79B | $34.64B | $36.44B | $39.63B | $43.49B | $48.87B | $54.30B | $66.13B | $69.01B | $71.58B | $77.63B | $79.95B | $66.42B | $59.71B | $62.95B | $61.16B | $65.12B | $97.15B | $91.84B | $90.59B |
| Cash & equivalents | $1.28B | $2.02B | $1.77B | $2.88B | $3.29B | $6.95B | $3.26B | $3.81B | $3.73B | $4.14B | $3.24B | $3.80B | $6.95B | $6.04B | $6.27B | $7.99B | $7.63B | $10.94B | $11.97B | — |
| Current assets | $11.71B | $13.04B | $15.22B | $18.93B | $23.13B | $27.59B | $31.21B | $27.37B | $34.71B | $38.52B | $46.01B | $49.48B | $37.62B | $18.44B | $21.14B | $19.39B | $22.19B | $30.33B | $29.03B | $29.06B |
| Total liabilities | $14.82B | $16.77B | $16.06B | $16.96B | $19.54B | $29.84B | $35.24B | $44.03B | $43.23B | $43.37B | $47.75B | $54.71B | $53.92B | $50.03B | $53.54B | $54.47B | $61.46B | $90.92B | $85.96B | $81.93B |
| Current liabilities | $7.02B | $6.18B | $4.89B | $3.87B | $6.57B | $5.75B | $8.19B | $7.95B | $7.01B | $8.66B | $11.20B | $9.02B | $13.49B | $12.84B | $11.65B | $12.18B | $15.69B | $18.39B | $23.10B | $25.49B |
| Long-term debt | $7.13B | $9.18B | $9.18B | $10.60B | $10.87B | $21.34B | $24.03B | $29.62B | $30.21B | $29.31B | $30.19B | $34.19B | $29.51B | $26.95B | $32.90B | $33.22B | $37.35B | $63.17B | $56.55B | — |
| Shareholder equity | $18.96B | $17.87B | $20.39B | $22.67B | $23.94B | $19.03B | $19.06B | $22.10B | $25.78B | $28.08B | $29.88B | $25.24B | $12.50B | $9.67B | $9.41B | $6.70B | $3.66B | $6.23B | $5.88B | — |
| Retained earnings | $-5.20B | $-7.16B | $-5.26B | $-4.32B | $-3.51B | $-8.92B | $-10.42B | $-7.63B | $-4.62B | $-2.09B | $-438.00M | $-5.07B | $-17.98B | $-21.33B | $-21.41B | $-24.60B | $-28.62B | $-26.55B | $-27.59B | — |
| Accounts receivable | $2.12B | $2.10B | $2.07B | $2.11B | $2.33B | $2.90B | $2.52B | $2.70B | $2.55B | $3.00B | $3.17B | $3.24B | $3.58B | $4.06B | $4.53B | $5.84B | $6.39B | $7.94B | $7.50B | $9.57B |
| Inventory | $1.90B | $2.09B | $2.08B | $2.22B | $2.02B | $2.48B | $2.74B | $3.02B | $2.65B | $2.44B | $2.75B | $2.83B | $2.94B | $3.58B | $3.89B | $4.09B | $4.93B | $9.52B | $7.00B | $6.22B |
| Goodwill | $11.30B | $11.24B | $11.34B | $11.34B | $11.33B | $11.75B | $12.66B | $14.97B | $14.79B | $14.79B | $14.75B | $14.76B | $14.70B | $14.70B | $14.69B | $14.89B | $15.53B | $18.63B | $18.64B | $18.68B |